RethinkPeptides
ArticlesTopicsResearch

Peptides and Addiction

3 articles in this topic.

Complete Guides

Peptides and AddictionGuide

GLP-1 Agonists and Addictive Behavior

Semaglutide and tirzepatide reduce alcohol, nicotine, and cocaine cravings through brain reward circuits. The research evidence from trials to mechanism.

20 min read|Mar 20, 2026

All Articles

Peptides and Addiction

Orexin Antagonists and Drug-Seeking Behavior

Orexin receptor antagonists reduce drug-seeking for opioids, cocaine, and alcohol in preclinical models. Review of SORA, DORA evidence and clinical trials.

16 min read|Mar 25, 2026
Peptides and Addiction

Vaccines for Nicotine and Cocaine: Can You Immunize Against Addiction?

Nicotine and cocaine vaccines use hapten-peptide conjugates to generate drug-blocking antibodies. NicVAX failed Phase 3. Fentanyl vaccines are entering trials.

13 min read|Mar 25, 2026

RethinkPeptides

Evidence-based peptide education. No hype, no sales. Just science.

Navigate

All ArticlesTopicsResearch DatabaseEvidence MethodologyDownload DataSearch

About

About UsEditorial PolicyMedical DisclaimerPrivacy PolicyTerms of Use

Disclaimer

Content on RethinkPeptides is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider. Peptides discussed here may not be approved for human use in your jurisdiction.

© 2026 RethinkPeptides. All rights reserved.